Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of unrelated peripheral blood stem cell transplantation with post-transplant cyclophosphamide for adult T-cell leukemia/lymphoma
jRCTs031200375Phase 2Active, not recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Jul 2021
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cyclophosphamide, tacrolimus and mycophenolate mofetil in adult T-cell leukemia-lymphoma (ATLL), sponsored by Japan Agency for Medical Research and Development. Started Jul 2021; status: active, not recruiting.
02
Drugs
cyclophosphamidetacrolimusmycophenolate mofetil
03
Conditions
adult T-cell leukemia-lymphoma (ATLL)
Beyond the preview
Go deeper on jRCTs031200375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200375.